Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry

Sponsor
Seoul National University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03513653
Collaborator
Seoul National University Bundang Hospital (Other), Chungnam National University Hospital (Other)
4,312
3
168
1437.3
8.6

Study Details

Study Description

Brief Summary

STRATS-AHF (STrain for Risk Assessment and Therapeutic Strategies in patients with Acute Heart Failure) registry enrolled 4,312 patients hospitalized for acute HF from 3 tertiary university hospitals (Seoul National University Bundang Hospital, Seoul National University Hospital, and Chungnam National University Hospital) from January 2009 through December 2016.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Echocardiography with speckle-tracking imaging

Detailed Description

Patients with signs or symptoms of heart failure and either lung congestion, or objective findings of left ventricular (LV) systolic dysfunction or structural heart disease, were eligible for the study. Echocardiography was performed and both LV ejection fraction (LVEF) and LV global longitudinal strain (LV-GLS), right ventricular GLS (RV-GLS) were measured.

Study Design

Study Type:
Observational
Actual Enrollment :
4312 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry
Actual Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Sep 5, 2017
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Acute heart failure

Patients hospitalized for acute heart failure and underwent echocardiography with speckle-tracking imaging

Diagnostic Test: Echocardiography with speckle-tracking imaging
Measurement of left ventricular ejection fraction and global longitudinal strain Measurement of left atrial reservoir strain (peak atrial longitudinal strain) Measurement of right ventricular global longitudinal strain

Outcome Measures

Primary Outcome Measures

  1. All-cause mortality [up to 5 years]

    Death from any cause

Secondary Outcome Measures

  1. Hospitalization for heart failure [up to 5 years]

    Any hospitalization for acute heart failure after the index hospitalization

  2. Composite of all-cause mortality and hospitalization for heart failure [up to 5 years]

    Death from any cause or any hospitalization for acute heart failure after the index hospitalization

  3. Ischemic stroke [up to 5 years]

    Ischemic stroke (an episode of neurological dysfunction caused by embolism) after the index hospitalization

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with signs or symptoms of HF and either lung congestion, or objective findings of LV systolic dysfunction or structural heart disease
Exclusion Criteria:
  • Patients who presented with acute coronary syndrome

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Korea, Republic of 13620
2 Chungnam National University Hospital Daejeon Korea, Republic of 35015
3 Seoul National University Hospital Seoul Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital
  • Seoul National University Bundang Hospital
  • Chungnam National University Hospital

Investigators

  • Principal Investigator: Goo-Yeong Cho, MD, PhD, Seoul National University Bundang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Goo-Yeong Cho, Professor, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT03513653
Other Study ID Numbers:
  • B-1702/384-111
First Posted:
May 1, 2018
Last Update Posted:
Oct 22, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Goo-Yeong Cho, Professor, Seoul National University Bundang Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2020